Nanobiotix (NBTX) Short Interest Ratio & Short Volume $3.84 -0.23 (-5.65%) (As of 11:28 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Nanobiotix Short Interest DataNanobiotix (NBTX) has a short interest of 33,800 shares. This marks a 10.46% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.7, indicating that it would take 3.7 days of the average trading volume of 17,197 shares to cover all short positions.Current Short Interest33,800 sharesPrevious Short Interest30,600 sharesChange Vs. Previous Month+10.46%Dollar Volume Sold Short$140,608.00Short Interest Ratio3.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares47,130,000 sharesPercentage of Shares Shorted0.07%Today's Trading Volume973 sharesAverage Trading Volume17,197 sharesToday's Volume Vs. Average6% Short Selling Nanobiotix? Sign up to receive the latest short interest report for Nanobiotix and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNBTX Short Interest Over TimeNBTX Days to Cover Over TimeNBTX Percentage of Float Shorted Over Time Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Nanobiotix Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202433,800 shares $140,608.00 +10.5%N/A3.7 $4.16 10/15/202430,600 shares $148,716.00 -8.1%N/A3.2 $4.86 9/30/202433,300 shares $191,475.00 -18.0%N/A3.5 $5.75 9/15/202440,600 shares $200,970.00 -19.4%N/A4.2 $4.95 8/31/202450,400 shares $302,400.00 -1.8%N/A6.2 $6.00 8/15/202451,300 shares $248,805.00 -0.8%N/A7 $4.85 Get the Latest News and Ratings for NBTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nanobiotix and its competitors with MarketBeat's FREE daily newsletter. 7/31/202451,700 shares $280,214.00 +2.0%N/A7.5 $5.42 7/15/202450,700 shares $277,329.00 -9.8%N/A6.7 $5.47 6/30/202456,200 shares $281,000.00 -0.5%N/A2.1 $5.00 6/15/202456,500 shares $259,900.00 +2.4%N/A1.6 $4.60 5/31/202455,200 shares $388,608.00 +1.3%N/A1.6 $7.04 5/15/202454,500 shares $398,395.00 -2.2%N/A1.5 $7.31 4/30/202455,700 shares $325,288.00 +5.7%N/A1.5 $5.84 4/15/202452,700 shares $294,593.00 +4.8%N/A1.5 $5.59 3/31/202450,300 shares $326,944.97 +4.1%N/A2.6 $6.50 3/15/202448,300 shares $335,685.00 +12.1%N/A3.8 $6.95 2/29/202443,100 shares $269,375.00 +0.2%N/A2.3 $6.25 2/15/202443,000 shares $317,340.00 +2.4%N/A2.3 $7.38 1/31/202442,000 shares $319,200.00 -7.9%N/A2.2 $7.60 1/15/202445,600 shares $357,960.00 +27.7%N/A2.3 $7.85 12/31/202335,700 shares $259,896.00 +113.8%N/A1.9 $7.28 12/15/202316,700 shares $104,208.00 +138.6%N/A0.9 $6.24 11/30/20237,000 shares $39,235.00 -23.1%N/A0.6 $5.61 11/15/20239,100 shares $53,144.00 -24.8%N/A0.4 $5.84 10/31/202312,100 shares $79,255.00 -36.7%N/A0.3 $6.55 10/15/202319,100 shares $127,970.00 +6.1%N/A0.4 $6.70 9/30/202318,000 shares $157,500.00 -4.3%N/A0.2 $8.75 9/15/202318,800 shares $177,039.60 -21.3%0.1%0.1 $9.42 8/31/202323,900 shares $218,446.00 -15.6%0.1%0.1 $9.14 8/15/202328,300 shares $234,041.00 -38.9%0.1%0.1 $8.27 7/31/202346,300 shares $356,973.00 -62.2%0.1%0.2 $7.71 7/15/2023122,400 shares $779,688.00 +367.2%0.4%0.1 $6.37 6/30/202326,200 shares $135,716.00 -22.0%0.1%0 $5.18 6/15/202333,600 shares $172,368.00 -8.5%0.1%0 $5.13 5/31/202336,700 shares $168,086.00 -49.9%0.1%0.1 $4.58 5/15/202373,200 shares $343,308.00 +850.7%0.2%0.1 $4.69 4/30/20237,700 shares $16,478.00 +28.3%0.0%0 $2.14 4/15/20236,000 shares $23,700.00 -22.1%0.0%3.5 $3.95 3/31/20237,700 shares $27,142.50 +30.5%0.0%5.9 $3.53 3/15/20235,900 shares $20,467.69 No Change0.0%4.2 $3.47JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 2/28/20235,900 shares $20,768.00 +391.7%0.0%4.2 $3.52 2/15/20231,200 shares $4,428.00 -33.3%N/A0.8 $3.69 1/31/20231,800 shares $7,686.00 +50.0%0.0%1.3 $4.27 1/15/20231,200 shares $5,136.84 -55.6%N/A1 $4.28 12/30/20222,700 shares $9,909.00 +42.1%0.0%1.6 $3.67 12/15/20221,900 shares $7,600.00 -9.5%0.0%1 $4.00 11/30/20222,100 shares $8,295.00 -25.0%0.0%1.1 $3.95 11/15/20222,800 shares $11,634.00 +40.0%0.0%1.3 $4.16 10/31/20222,000 shares $7,920.00 -64.9%0.0%0.9 $3.96 10/15/20225,700 shares $20,007.00 -52.1%0.0%1.7 $3.51 9/30/202211,900 shares $42,126.00 +30.8%0.0%4.1 $3.54 9/15/20229,100 shares $38,675.00 +116.7%0.0%3.5 $4.25 8/31/20224,200 shares $16,758.00 -2.3%0.0%1.7 $3.99 8/15/20224,300 shares $19,608.00 +168.8%0.0%1.9 $4.56 7/31/20221,600 shares $3,712.00 -33.3%N/A0.8 $2.32 7/15/20222,400 shares $8,448.00 +33.3%0.0%3 $3.52 6/30/20221,800 shares $6,840.00 +63.6%0.0%2.3 $3.80 6/15/20221,100 shares $4,246.00 +10.0%N/A0.7 $3.86 5/31/20221,000 shares $5,230.00 No ChangeN/A0.7 $5.23 5/15/20221,000 shares $5,266.00 -44.4%N/A0.6 $5.27 4/30/20221,800 shares $10,620.00 +100.0%0.0%0.6 $5.90 4/15/2022900 shares $5,850.00 +12.5%N/A0.2 $6.50 3/31/2022800 shares $5,952.00 -38.5%N/A0.2 $7.44 3/15/20221,300 shares $8,528.00 +30.0%N/A0.2 $6.56 2/28/20221,000 shares $7,540.00 -9.1%N/A0.1 $7.54 2/15/20221,100 shares $9,878.00 -69.4%N/A0.1 $8.98 1/31/20223,600 shares $27,540.00 -26.5%0.0%0.5 $7.65 1/15/20224,900 shares $44,786.00 +345.5%0.0%1 $9.14 12/31/20211,100 shares $8,910.00 -8.3%N/A0.2 $8.10 12/15/20211,200 shares $8,928.00 -58.6%N/A0.3 $7.44 11/30/20212,900 shares $24,592.00 +16.0%0.0%0.7 $8.48 11/15/20212,500 shares $23,750.00 -64.8%0.0%1 $9.50 10/29/20217,100 shares $74,053.00 -36.6%0.0%3.4 $10.43 10/15/202111,200 shares $143,584.00 -0.9%0.0%4.9 $12.82 9/30/202111,300 shares $128,368.00 -11.7%0.0%4 $11.36 9/15/202112,800 shares $153,195.52 +392.3%0.0%5.8 $11.97 8/31/20212,600 shares $32,760.00 -27.8%0.0%1.2 $12.60 8/13/20213,600 shares $46,440.00 -73.1%0.0%1.3 $12.90 7/30/202113,400 shares $197,382.00 +19.6%0.0%4.6 $14.73 7/15/202111,200 shares $166,432.00 -11.1%N/A4.3 $14.86 6/30/202112,600 shares $173,628.00 No ChangeN/A6.6 $13.78 6/15/202112,600 shares $195,048.00 +31.3%N/A2.9 $15.48 5/28/20219,600 shares $164,352.00 -28.9%N/A2.1 $17.12 5/14/202113,500 shares $205,200.00 +60.7%N/A3 $15.20 4/30/20218,400 shares $133,728.00 -34.4%N/A1.4 $15.92 4/15/202112,800 shares $196,736.00 +85.5%N/A1.6 $15.37 3/31/20216,900 shares $104,742.00 -28.9%N/A0.6 $15.18 3/15/20219,700 shares $157,225.36 -32.2%N/A0.6 $16.21 2/26/202114,300 shares $237,094.00 -22.3%N/A0.4 $16.58 2/12/202118,400 shares $334,696.00 +11.5%N/A0.4 $18.19JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 1/29/202116,500 shares $287,100.00 -21.4%N/A0.3 $17.40 1/15/202121,000 shares $373,800.00 No ChangeN/A0.3 $17.80 NBTX Short Interest - Frequently Asked Questions What is Nanobiotix's current short interest? Short interest is the volume of Nanobiotix shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 33,800 shares of NBTX short. Learn More on Nanobiotix's current short interest. What is a good short interest ratio for Nanobiotix? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NBTX shares currently have a short interest ratio of 4.0. Learn More on Nanobiotix's short interest ratio. Is Nanobiotix's short interest increasing or decreasing? Nanobiotix saw a increase in short interest in October. As of October 31st, there was short interest totaling 33,800 shares, an increase of 10.5% from the previous total of 30,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Nanobiotix's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Nanobiotix: Anavex Life Sciences Corp. (21.59%), CorMedix Inc. (10.35%), Entrada Therapeutics, Inc. (7.68%), Arbutus Biopharma Co. (3.45%), Dianthus Therapeutics, Inc. (25.20%), Phathom Pharmaceuticals, Inc. (25.52%), Exscientia plc (2.55%), ORIC Pharmaceuticals, Inc. (16.51%), Stoke Therapeutics, Inc. (12.65%), Oculis Holding AG (0.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Nanobiotix stock? Short selling NBTX is an investing strategy that aims to generate trading profit from Nanobiotix as its price is falling. NBTX shares are trading up $0.29 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nanobiotix? A short squeeze for Nanobiotix occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NBTX, which in turn drives the price of the stock up even further. How often is Nanobiotix's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NBTX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies CARGO Therapeutics Short Interest Data Erasca Short Interest Data Cullinan Therapeutics Short Interest Data Entrada Therapeutics Short Interest Data Tectonic Therapeutic Short Interest Data Arbutus Biopharma Short Interest Data CorMedix Short Interest Data AnaptysBio Short Interest Data Phathom Pharmaceuticals Short Interest Data Exscientia Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NBTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanobiotix S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanobiotix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NBTX Stock Alerts